Related Experiment Video
Updated: May 4, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
2.2K
[Cognitive decline in elderly individuals with type 2 diabetes mellitus]
1Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 9, 2014
Summary
Cognitive decline in elderly patients with diabetes complicates management and worsens health outcomes. Simultaneous treatment of both conditions is crucial for better glycemic control and reduced complications.
Area of Science:
- Gerontology
- Endocrinology
- Neurology
Context:
- Diabetes mellitus is a prevalent condition in the elderly population.
- Cognitive decline, including dementia, frequently coexists with diabetes.
- This comorbidity presents significant challenges in managing both conditions effectively.
Purpose:
- To review current evidence on glycemic control targets for elderly patients with diabetes and cognitive impairment.
- To discuss the appropriate selection and use of anti-diabetic medications in this vulnerable population.
- To highlight the need for a multidisciplinary approach in managing diabetic elderly with cognitive decline.
Summary:
- Cognitive impairment in diabetic patients negatively impacts daily living activities and life expectancy.
- The interplay between cognitive dysfunction and hyperglycemia creates a cycle that worsens diabetic control and increases risks of acute metabolic failure.
- Elderly individuals with cognitive decline exhibit poor compliance with diabetes treatment, necessitating comprehensive care strategies.
Impact:
- Optimizing glycemic control in diabetic elderly with cognitive impairment can improve health outcomes.
- Appropriate anti-diabetic medication selection is vital to prevent adverse events and manage comorbidities.
- A coordinated, multidisciplinary approach is essential for effective management and improved quality of life.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17